Data / Form D filings / Araim Pharmaceuticals, Inc.
Araim Pharmaceuticals, Inc.: Form D filings
Araim Pharmaceuticals, Inc., a pharmaceuticals company in Tarrytown, NY, filed 3 Form D notices with the SEC between 2014 and 2017. The latest, on November 15, 2017, reports $4.1 million sold of a $4.1 million offering to 5 investors.
Find out what Araim Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 580 WHITE PLAINS ROAD, SUITE 210, Tarrytown, NY, 10591
- Phone
- (914) 762-7586
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1625178
The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 15, 2017 | Amendment | $4,102,429 | $4,102,429 | $0 | 5 | Aug 29, 2017 | sec.gov |
| Sep 13, 2017 | New notice | $4,002,429 | $4,002,429 | $0 | 4 | Aug 29, 2017 | sec.gov |
| Nov 17, 2014 | New notice | $4,000,000 | $4,000,000 | $0 | 5 | Nov 5, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Rita Kirk | Executive Officer | |
| Sidney Strickland | Director | |
| Anthony Cerami | Director | |
| Gerald Bernstein | Director | |
| Michael Brines | Executive Officer, Director | |
| Ferry Breedveld | Director | |
| John Macomber | Director | |
| Ann Dunne | Executive Officer, Director |
Other pharmaceuticals companies in New York that filed recently
- NBO Pharma Inc. $238,000 · Nov 9, 2026
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Nov 13, 2017 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Araim Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.